The Tennessee Public Health Association and the Tennessee Medical Association are collaborating to establish the “William Schaffner, M.D., Public Health Hero Award,” to be presented annually to an individual who has demonstrated extraordinary efforts in the advancement of public health in Tennessee.

A Vanderbilt lung cancer patient’s exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways.

In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis.

Colorectal cancer is one of the leading causes of death among populations around the world. While diet, physical activity and other lifestyle factors can influence the risk of developing the disease, hereditary factors also play an important role.

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.

Applicants to the Vanderbilt Medical Scholars Program, a yearlong, in-depth research experience, have been successful in obtaining both internal and external research funding this year.

Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation.